Newton Partners with Hong Kong Optical Lens to Expand Distribution in Asia

牛顿与香港光学镜片合作，扩大在亚洲的分销网络

November 20, 2025

2025年11月20日

Newton (formerly Neurolens) has announced a partnership with Hong Kong Optical Lens Co (HKO), which will serve as the exclusive distributor of Newton’s therapeutic lens technologies in Hong Kong and China. The agreement expands access to the Neurolens and Sequel lens portfolios in two of the world’s most digitally connected markets..

牛顿公司（原名Neurolens）宣布与香港光学镜片有限公司（HKO）达成合作伙伴关系，后者将成为牛顿治疗性镜片技术在香港和中国的独家经销商。该协议将扩大Neurolens和Sequel镜片系列在两个全球数字化程度最高的市场的覆盖范围。

Collaboration Includes Educational and Clinical Integration

协作包括教育和临床整合

Newton’s entry into Hong Kong is supported by HKO’s strategic partner, CMER Eye Centers, which has introduced the Neurolens N3 diagnostic device into its practice.

牛顿进入香港市场得到了香港视光的战略合作伙伴 CMER 眼科中心的支持，该中心已将其执业中引入了 Neurolens N3 诊断设备。

As part of a joint educational initiative, HKO and Newton have donated N3 devices to The Hong Kong Polytechnic University School of Optometry. The collaboration aims to provide optometry students with training opportunities using the diagnostic system.

作为联合教育计划的一部分，HKO 和 Newton 向香港理工大学视光学院捐赠了 N3 设备。此次合作旨在为视光学学生提供使用诊断系统的培训机会。

Technologies Designed for Visual Alignment and Digital Eye Strain

专为视觉对齐和数字眼疲劳设计的技术

The N3 diagnostic device provides objective measurement of eye misalignment, supporting the evaluation of binocular vision issues.

N3诊断设备提供眼位偏移的客观测量，支持对双眼视觉问题的评估。

Neurolens therapeutic lenses incorporate Contoured Prism technology, developed to address symptoms such as headaches, neck pain, motion sickness, and eye strain associated with visual misalignment. According to the company, the lenses have demonstrated symptom relief in up to 90% of affected patients..

Neurolens治疗镜片融入了轮廓棱镜技术，旨在解决与视觉错位相关的头痛、颈痛、晕动症和眼疲劳等症状。据公司称，这些镜片在多达90%的受影响患者中已显示出症状缓解效果。

The Sequel everyday lens is intended for daily wear and is designed to help prevent and alleviate digital eye strain. It uses Convergence Boost technology to support visual comfort during extended periods of screen use.

Sequel日常镜片旨在日常佩戴，有助于预防和缓解数字眼疲劳。它采用Convergence Boost技术，在长时间使用屏幕时提供视觉舒适支持。

Statements from Leadership

领导层声明

Davis Corley, CEO of Newton, commented on the announcement:

牛顿公司首席执行官戴维斯·科利对这一声明发表了评论：

“This partnership marks an important step in Newton’s international expansion. Hong Kong Optical Lens’ market expertise positions us to reach individuals experiencing headaches, neck pain, motion sickness, and digital eye strain.”

“这一合作标志着牛顿国际扩张的重要一步。香港光学镜头的市场专业知识使我们能够接触到经历头痛、颈部疼痛、晕动症和数字眼疲劳的人群。”

“Our legacy is rooted in a partner-first philosophy, working closely with global brands, to transform market insights into reality. We are excited to partner with Newton to bring the cutting-edge Neurolens and Sequel technologies to Hong Kong and China,” added Eddie So, Managing Director of Hong Kong Optical Lens..

“我们的传统植根于以合作伙伴为先的理念，与全球品牌紧密合作，将市场洞察转化为现实。我们很高兴与牛顿合作，将前沿的Neurolens和Sequel技术带到香港和中国，”香港光学镜片董事总经理苏炳豪补充道。